European Archives - Page 505 of 1164 - European Medical Journal

Tackling the trust gap in genomic medicine

How can pharma tackle public mistrust in genomic medicine?

Protective Effects of BCG Vaccine In COVID-19

In novel results published from a double-blind, placebo-controlled study of patients with Type 1 diabetes, researchers demonstrated a protective effect of Bacillus Calmette–Guerin (BCG) vaccine.

Reframing pharma's bad boy reputation

The pharmaceutical industry is a rich source of material for the small screen, but why is it framed as the perpetual bad boy?

Sanofi’s Dr Juby Jacob-Nara on medical affairs and mentorship

How does a physician make a difference in medical affairs? Juby Jacob-Nara tells her story.

Diencephalic Syndrome: Anaesthetic Management and Post-Operative Complications

Diencephalic syndrome (DS), first described by Russell in 1951, is a rare cause of failure to thrive in infants and young children with preservation of linear growth.

Innovative Upper Gastrointestinal Stenting

Self-expanding metal stents (SEMS) have been established beyond doubt as an effective tool in the palliative management of malignant gastrointestinal tract strictures.

Increasing Awareness in Beta-Thalassemia

This series of webinars focusses on Beta-Thalassemia. These are scientific presentations and discussions for the purpose of scientific exchange.

The Efficacy of Anti-TNFs in Immune-Mediated Disease

TNF-α is produced in high concentrations in chronic inflammatory disease, resulting in excessive inflammation which eventually leads to organ damage. The advent of anti-TNF therapy in clinical practice 20 years ago represented a significant change in the management of immune-mediated inflammatory diseases (IMIDs), including rheumatoid arthritis (RA), axial spondylarthritis (SpA), psoriasis, and inflammatory bowel disease (IBD).

EMJ Gastroenterology 11 [Supplement 5] 2022

TNF-α is produced in high concentrations in chronic inflammatory disease, resulting in excessive inflammation which eventually leads to organ damage. The advent of anti-TNF therapy in clinical practice 20 years ago represented a significant change in the management of immune-mediated inflammatory diseases (IMIDs), including rheumatoid arthritis (RA), axial spondylarthritis (SpA), psoriasis, and inflammatory bowel disease (IBD).

Expert Insights into Updated Advanced HF Management Guidelines Comparing AHA/ACC/HFSA and ESC Guidelines

Discover Professor Antoni Bayés-Genís’ view on the evolution of left ventricular assist devices and his comments related to the AHA/ACC/HFSA guidelines in comparison to the 2021 ESC heart failure guidelines.